These emerging findings have significantly affected the traditional practice of oncology and have resulted in a subspecialized multidisciplinary approach to patient care that incorporates personalized therapies such as targeted molecular therapy, prognosis, risk assessment, and prevention, all of which are primarily based on molecular diagnostics and imaging.
CARS is a label-free imaging technique based on molecular vibrations that are excited with IR light (Evans and Xie 2008; Le et al. 2010; Muller and Zumbusch 2007).
Such techniques include electron/ion microscopy, satellite imaging, tomography, NMR and, more recently, mass spectrometry based on molecular or elemental-based techniques [1 4].
The increasing introduction of individualized concepts for therapy, which will then be also based on molecular markers, will to a high degree rely on multimodal functional and metabolic imaging.
The modern transformation of radiology into an essential guiding hand of medical practice began with the invention of computed tomography imaging in the early 1970s and continues today with novel applications based on molecular methods and nanotechnology.
Protein GO enrichment based on molecular functions.
In these cases, diffusion-weighted MR imaging (DWI) might be of value in tumour assessment, as it has the ability to provide tissue contrast based on molecular diffusion [5].
Its learning is based on molecular evolution.
Remarkably, Jagoda and colleagues not only conducted leading work in the development of antibody-based c-MET-targeted molecular imaging but they also performed extensive research on molecular imaging based on cMBP [67, 68].
For example, scientists from GlaxoSmithKline, the pharmaceutical company, often visit, interested in the work on molecular imaging.
